Financials
Financial year 2025
IDESPHARMA from Koksijde, company number BE0764318824, closed financial year 2025 with a result of € -6,436 after tax. For that financial year IDESPHARMA recorded a gross margin of € 191,450 and equity of € 353,392. Compared with financial year 2024, the result moved from € 97,266 to € -6,436. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on December 4, 2025.
€ 353,392
▼ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6,436
▼ still € 97,266 profit in 2024
Profit after tax over the fiscal year.
€ 60,187
▲ 139% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 348,392.
People and assets in 2025
2
▲ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 162,690
▲ 144% vs 2024
€ 81,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 70,716
▼ 27% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 17,291
▼ 56% vs 2024
Loans from banks and other lenders, long and short.
€ 47,842
▼ 54% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,757
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 234,312 | € 249,994 | € 245,201 | € 191,450 | ▼ 22% |
| Profit after taxes | € 142,406 | € 115,157 | € 97,266 | € -6,436 | ▼ € 103,703 |
| Equity | € 147,406 | € 262,562 | € 359,829 | € 353,392 | ▼ 2% |
| Total debts | € 246,104 | € 217,819 | € 1,004,768 | € 986,579 | ▼ 2% |
| Cash | € 134,206 | € 84,433 | € 25,147 | € 60,187 | ▲ 139% |
| Retained profit | € 142,406 | € 257,562 | € 354,829 | € 348,392 | ▼ 2% |
| Bank debt | € 0 | € 60,840 | € 39,519 | € 17,291 | ▼ 56% |
| Balance sheet total | € 393,510 | € 480,382 | € 1,364,597 | € 1,339,972 | ▼ 2% |
| Employees (FTE) | 0.4 | 1 | 1 | 2 | ▲ 1 |
Key figures of IDESPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to IDESPHARMA?
What happened at IDESPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6,436 (▼ € 103,703 vs 2024). Source: NBB ↗
- New establishment in Koksijde. KBO
- Start of the company according to the CBE. KBO
In short
From € 142,406 profit in 2022 to € 6,436 loss in 2025.
Paid € 153,219 in corporate taxes since 2022.
Best year ever: 2022, with € 142,406 profit.
On average € 95,700 of value added per employee in 2025.
Management
Behind IDESPHARMA is Julie Van Schoote. Julie Van Schoote is also behind APOTHEEK VERSTEELE and LAEREMANS WIJNEN.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Dageraadstraat(Kok) 11
8670 Koksijde
Strandlaan(Kok) 282
8670 Koksijde
Active since 1 April 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0764.318.824
- VAT number
- BE 0764.318.824
- Registered office
- Dageraadstraat(Kok) 11, 8670 Koksijde
- Names & denominations
- IDESPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 February 2021
- Peppol
- Active · Active since 12 Feb 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Overige detailhandel in voedingsmiddelen, neg
Detailhandel in cosmetica en toiletartikelen
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.